跳至主要内容
临床试验/NCT03583359
NCT03583359已完成不适用

Evaluation of Effectiveness and Safety of Radiesse (+) to Improve the Contour of Jawline by Adding Volume to the Jawline

Merz North America, Inc.28 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2018年8月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
180
试验地点
28
主要终点
Responder Rate According to the Merz Jawline Assessment Scale (MJAS)

研究概览

简要总结

To demonstrate the effectiveness and safety of Radiesse (+) following deep (subdermal and/or supraperiosteal) injection to improve the contour of jawline by adding volume to the jawline.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
22 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Has right and left jawline ratings of 2 or 3 (moderate or severe) on the Merz Jawline Assessment Scale (MJAS).
  • Has the same MJAS score on both jawlines (that is, jawlines are symmetrical).
  • Is greater than or equal to (>=) 22 and less than or equal to (<=) 65 years of age.

排除标准

  • Ever been treated with fat injections or permanent fillers (example, silicone, polymethylmethacrylate (PMMA)) in the lower face and/or jawline area or plans to receive such treatments during participation in the study.
  • Been treated with semi-permanent dermal fillers (example, poly L-lactic acid) in the lower face and/or jawline area in the past 5 years or plans to receive such treatments during participation in the study.

结局指标

主要结局

Responder Rate According to the Merz Jawline Assessment Scale (MJAS)

时间窗: At Week 12

MJAS was a 5-point scale (0-4 scores; higher scores mean worse outcome). Responder rate was defined as percentage of participants with a greater than or equal to (\>=) 1-point improvement.

Number of Participants Reporting One or More Device and/or Injection Related Treatment-emergent Adverse Events (TEAEs) and Device and/or Injection Related Serious TEAEs

时间窗: Baseline up to end of study (Week 60)

次要结局

  • GAIS Scores as Assessed by Participants(At Week 12)
  • Percent Change From Baseline in Face-Q Satisfaction(Baseline up to Week 12)
  • Responder Rate According to the MJAS as Assessed by Independent Panel Reviewers (IPRs)(At Week 12)
  • Global Aesthetic Improvement Scale (GAIS) Scores as Assessed by the Treating Investigator(At Week 12)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (28)

Loading locations...

相似试验